<?xml version="1.0" encoding="UTF-8"?>
<p id="Par81">The history and role of NHPs in the epidemiology of YFV around the world is well documented [
 <xref ref-type="bibr" rid="CR3">3</xref>, 
 <xref ref-type="bibr" rid="CR6">6</xref>, 
 <xref ref-type="bibr" rid="CR60">60</xref>, 
 <xref ref-type="bibr" rid="CR94">94</xref>] and the early investigations into the epidemiology of YFV led to the development of the concepts of arboviral sylvatic cycles in NHPs that we have today [
 <xref ref-type="bibr" rid="CR13">13</xref>, 
 <xref ref-type="bibr" rid="CR94">94</xref>]. Yellow fever outbreaks continue in Africa and South America and can be extensive. Most YFV infections in people are subclinical but signs can range from mild fever, myalgia, headache and nausea with a rapid recovery to high fever, abdominal pain, jaundice, hepatitis, haemorrhagic diatheses and death [
 <xref ref-type="bibr" rid="CR47">47</xref>]. The YFV is the archetypal 
 <italic>Flavivirus</italic> and exists in seven genotypes [
 <xref ref-type="bibr" rid="CR6">6</xref>].
</p>
